FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to urology and oncology. Clinic examination is carried out and clinical-laboratory indices are determined: extent of operative interference, presence of remote metastases and tumor invasion are taken into account, thrombus dimensions and concentration of fibrinogen in blood serum are determined. Life duration of patient in months (Y) is determined by formula: Y = 43.1 - 19.4·X1 - 2.58·X2 + 2.8·X3 - 0.63·X4 + 2.4·X5, where X1"Д"…5 are gradations and numerical values of risk factors, X1 is operation volume: radical - 1, palliative - 2; X2 - remote metastases: in lungs -1, in liver -2, in other organs -3; X3 - tumor invasion: no -1, microinvasion - 1, into wall of vena cava - 2, in renal vein -3; X4 - thrombus dimensions, cm; X5 - fibrinogen, g/l.
EFFECT: method provides possibility to predict expected life duration of patients in months by determining indices of standard patient examination and taking into account performed operative treatment.
2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREDICTION OF DEVELOPING HAEMATOGENOUS METASTASES FOLLOWING COMBINED TREATMENT OF KIDNEY CANCER | 2013 |
|
RU2528100C1 |
METHOD FOR PREDICTING THE COURSE OF THE DISEASE IN PATIENTS WITH LOCAL RENAL CELL CARCINOMA OF THE KIDNEY | 2018 |
|
RU2674677C1 |
METHOD OF PREDICTING LIFE EXPECTANCY AT SICK OF METASTATIC CANCER OF PROSTATE | 2007 |
|
RU2340286C1 |
METHOD OF PREDICTING OF LIFE EXPECTANCY OF PATIENTS WITH LOCAL CANCER OF PROSTATE | 2007 |
|
RU2341197C1 |
METHOD OF PREDICTING HEMATOGENOUS METASTASIS OF COLON CANCER AFTER COMBINED TREATMENT | 2023 |
|
RU2797845C1 |
METHOD FOR LIFESPAN EVALUATION IN PATIENTS WITH LOCALLY ADVANCED AND DISSEMINATED RENAL CELL CARCINOMA | 2009 |
|
RU2405150C1 |
METHOD FOR PREOPERATIVE RISK PREDICTION OF LYMPHOGENIC METASTASIS IN STAGE T1 ENDOMETRIAL CANCER | 2018 |
|
RU2687870C1 |
METHOD FOR PREOPERATIVE PREDICTION OF THE RISK OF LYMPHATIC METASTASIS IN PATIENTS WITH ENDOMETRIAL CANCER T1 INTERMEDIATE RISK STAGE WITH METABOLIC SYNDROME | 2020 |
|
RU2737130C1 |
METHOD FOR PREDICTION OF RISK OF DEVELOPING DISTANT METASTASES IN PATIENTS WITH OPERABLE FORMS OF BREAST CANCER WITH METASTASES IN REGIONAL LYMPH NODES | 2020 |
|
RU2733697C1 |
METHOD FOR DISTANT METASTASES DEVELOPMENT RISK DEGREE DETERMINATION FOR PATIENTS WITH COLON CANCER | 2016 |
|
RU2623119C1 |
Authors
Dates
2009-11-27—Published
2008-07-14—Filed